Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMG Pharmaceutical
Seoul, South Korea
- Ownership
- Private
- Employees
- ~273
- Development stage
- Other
01
Overview
CMG Pharmaceutical has multiple drugs approved in South Korea, primarily small molecules and fixed-dose combinations for conditions like allergic rhinitis, common cold, and type 2 diabetes. The company is also developing novel synthetic drugs in oncology targeting cancers such as solid tumors and ovarian cancer, as well as advancing OTF (oral thin film) technology and new chemical entities. Several programs are in pre-clinical or development stages, and the company is active in both the generic and innovative drug space.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesOtherOncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on CMG Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CMG Pharmaceutical.